Form 4 for CRSP CRISPR Therapeutics AG
Accepted 2024-08-12 00:00:00 ET · period of report 2024-08-08 · accession 0000950170-24-095615 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-12 | 2024-08-08 | CRSP | Kulkarni Samarth | CEO, Dir | G - Gift | $0.00 | -100.0K | 222.5K | -31% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-08-08 | G | D | 100,000 | $0.00 | 222,500 | D | — | — | (F1) Reflects 114,378 shares previously transferred from the Kulkarni 2023 GRAT to the Reporting Person. |